Interplay Between Microglia and Environmental Risk Factors in Alzheimer's Disease

Overview

Journal Neural Regen Res

Date 2023 Dec 16

PMID 38103237

Authors

Miaoping Zhang

Chunmei Liang

Xiongjin Chen

Yujie Cai

Lili Cui

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease, among the most common neurodegenerative disorders, is characterized by progressive cognitive impairment. At present, the Alzheimer's disease main risk remains genetic risks, but major environmental factors are increasingly shown to impact Alzheimer's disease development and progression. Microglia, the most important brain immune cells, play a central role in Alzheimer's disease pathogenesis and are considered environmental and lifestyle "sensors." Factors like environmental pollution and modern lifestyles (e.g., chronic stress, poor dietary habits, sleep, and circadian rhythm disorders) can cause neuroinflammatory responses that lead to cognitive impairment via microglial functioning and phenotypic regulation. However, the specific mechanisms underlying interactions among these factors and microglia in Alzheimer's disease are unclear. Herein, we: discuss the biological effects of air pollution, chronic stress, gut microbiota, sleep patterns, physical exercise, cigarette smoking, and caffeine consumption on microglia; consider how unhealthy lifestyle factors influence individual susceptibility to Alzheimer's disease; and present the neuroprotective effects of a healthy lifestyle. Toward intervening and controlling these environmental risk factors at an early Alzheimer's disease stage, understanding the role of microglia in Alzheimer's disease development, and targeting strategies to target microglia, could be essential to future Alzheimer's disease treatments.

Citing Articles

The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer's disease.

Liu X, Wu W, Li X, Wang C, Chai K, Yuan F Neural Regen Res. 2024; 20(11):3330-3344.

PMID: 39715098 PMC: 11881737. DOI: 10.4103/NRR.NRR-D-23-01890.

Hallmarks of aging in age-related macular degeneration and age-related neurological disorders: novel insights into common mechanisms and clinical relevance.

Vujosevic S, Limoli C, Kozak I Eye (Lond). 2024; .

PMID: 39289517 DOI: 10.1038/s41433-024-03341-5.

Trajectory of brain-derived amyloid beta in Alzheimer's disease: where is it coming from and where is it going?.

Liu N, Haziyihan A, Zhao W, Chen Y, Chao H Transl Neurodegener. 2024; 13(1):42.

PMID: 39160618 PMC: 11331646. DOI: 10.1186/s40035-024-00434-9.

Glycolytic dysregulation in Alzheimer's disease: unveiling new avenues for understanding pathogenesis and improving therapy.

Wu Y, Yang L, Jiang W, Zhang X, Yao Z Neural Regen Res. 2024; 20(8):2264-2278.

PMID: 39101629 PMC: 11759019. DOI: 10.4103/NRR.NRR-D-24-00190.

Potential role of tanycyte-derived neurogenesis in Alzheimer's disease.

Qi G, Tang H, Hu J, Kang S, Qin S Neural Regen Res. 2024; 20(6):1599-1612.

PMID: 38934388 PMC: 11688558. DOI: 10.4103/NRR.NRR-D-23-01865.

References

Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T . Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. Cell Res. 2019; 29(10):787-803. PMC: 6796854. DOI: 10.1038/s41422-019-0216-x. View

Orihuela R, McPherson C, Harry G . Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 2015; 173(4):649-65. PMC: 4742299. DOI: 10.1111/bph.13139. View

Wang B, Shi J, Ge N, Ou Z, Tian Y, Jiang T . PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer's disease. J Neuroinflammation. 2018; 15(1):132. PMC: 5932821. DOI: 10.1186/s12974-018-1178-5. View

Bisht K, Sharma K, Tremblay M . Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. Neurobiol Stress. 2018; 9:9-21. PMC: 6035903. DOI: 10.1016/j.ynstr.2018.05.003. View

Faustino J, Wang X, Johnson C, Klibanov A, Derugin N, Wendland M . Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci. 2011; 31(36):12992-3001. PMC: 3539822. DOI: 10.1523/JNEUROSCI.2102-11.2011. View

Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

Plascencia-Villa G, Perry G . Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis. Antioxid Redox Signal. 2020; 34(8):591-610. PMC: 8098758. DOI: 10.1089/ars.2020.8134. View

Herr D, Jew K, Wong C, Kennell A, Gelein R, Chalupa D . Effects of concentrated ambient ultrafine particulate matter on hallmarks of Alzheimer's disease in the 3xTgAD mouse model. Neurotoxicology. 2021; 84:172-183. PMC: 8268836. DOI: 10.1016/j.neuro.2021.03.010. View

Alahmari A . Blood-Brain Barrier Overview: Structural and Functional Correlation. Neural Plast. 2021; 2021:6564585. PMC: 8668349. DOI: 10.1155/2021/6564585. View

10.

Durazzo T, Korecka M, Trojanowski J, Weiner M, O Hara R, Ashford J . Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers. J Alzheimers Dis. 2016; 54(1):99-107. PMC: 5127393. DOI: 10.3233/JAD-160413. View

11.

Shi J, Wang B, Jiang T, Gao L, Zhang Y, Xu J . NLRP3 Inflammasome: A Potential Therapeutic Target in Fine Particulate Matter-Induced Neuroinflammation in Alzheimer's Disease. J Alzheimers Dis. 2020; 77(3):923-934. DOI: 10.3233/JAD-200359. View

12.

Arango-Lievano M, Peguet C, Catteau M, Parmentier M, Wu S, Chao M . Deletion of Neurotrophin Signaling through the Glucocorticoid Receptor Pathway Causes Tau Neuropathology. Sci Rep. 2016; 6:37231. PMC: 5110980. DOI: 10.1038/srep37231. View

13.

Yulug B, Hanoglu L, Ozansoy M, Isik D, Kilic U, Kilic E . Therapeutic role of rifampicin in Alzheimer's disease. Psychiatry Clin Neurosci. 2018; 72(3):152-159. DOI: 10.1111/pcn.12637. View

14.

Yang L, Yu X, Zhang Y, Liu N, Xue X, Fu J . Caffeine treatment started before injury reduces hypoxic-ischemic white-matter damage in neonatal rats by regulating phenotypic microglia polarization. Pediatr Res. 2022; 92(6):1543-1554. PMC: 9771815. DOI: 10.1038/s41390-021-01924-6. View

15.

Hinwood M, Tynan R, Charnley J, Beynon S, Day T, Walker F . Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline. Cereb Cortex. 2012; 23(8):1784-97. DOI: 10.1093/cercor/bhs151. View

16.

Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G . Inflammation and Alzheimer's disease. Neurobiol Aging. 2000; 21(3):383-421. PMC: 3887148. DOI: 10.1016/s0197-4580(00)00124-x. View

17.

Irwin M, Vitiello M . Implications of sleep disturbance and inflammation for Alzheimer's disease dementia. Lancet Neurol. 2019; 18(3):296-306. DOI: 10.1016/S1474-4422(18)30450-2. View

18.

Milior G, Lecours C, Samson L, Bisht K, Poggini S, Pagani F . Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress. Brain Behav Immun. 2015; 55:114-125. DOI: 10.1016/j.bbi.2015.07.024. View

19.

Son Y, Jeong Y, Shin N, Oh S, Nam K, Choi H . Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice. Int J Mol Sci. 2020; 21(15). PMC: 7432084. DOI: 10.3390/ijms21155553. View

20.

Bakulski K, Dolinoy D, Sartor M, Paulson H, Konen J, Lieberman A . Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis. 2012; 29(3):571-88. PMC: 3652332. DOI: 10.3233/JAD-2012-111223. View